Ground News

See the Full Picture.

Managed Healthcare Executive image

News from Managed Healthcare Executive

All of today’s top news stories from Managed Healthcare Executive. Get the full analysis behind how media bias impacts breaking news.

We’ve discovered 352 headlines written by Managed Healthcare Executive during the past 3 months.

Managed Healthcare Executive’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Managed Healthcare Executive’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Managed Healthcare Executive

Where is Managed Healthcare Executive located?Managed Healthcare Executive's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Managed Healthcare Executive News

Work requirements could transform Medicaid and food aid under US budget bill

Medicaid · United States

Work requirements could transform Medicaid and food aid under US budget bill

56% Center coverage: 173 sources

The U.S. social safety net would be jolted if the budget bill backed by President Donald Trump and passed Thursday by the House of Representatives becomes law. It would impose work requirements for low-income adults to receive Medicaid health insurance and increase them for food assistance as well as cut funding for services like birth control to the nation’s biggest abortion provider.See the Story

CVS and Express Scripts sue Arkansas over restriction on pharmacy benefit managers

CVS · Arkansas

CVS and Express Scripts sue Arkansas over restriction on pharmacy benefit managers

47% Left coverage: 19 sources

Alcon Announces FDA Approval of TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease

United States · United States

Alcon Announces FDA Approval of TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease

67% Center coverage: 3 sources

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. Food and Drug Administration (FDA) has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment of signs and symptoms of Dry Eye Disease (DED).3 TRYPTYR is a first-in-class TRPM8 receptor agonist (neuromodulator) that stimulates […]See the Story

Blindspots

CVS and Express Scripts sue Arkansas over restriction on pharmacy benefit managers

CVS and Express Scripts sue Arkansas over restriction on pharmacy benefit managers

CVS and Express Scripts sue Arkansas over restriction on pharmacy benefit managers

Combination Therapies: Satellos CSO on Future of Treatment – Archyde

Archyde The Future of Duchenne Muscular Dystrophy Treatment: Why Combination Therapies Are Likely the Key Imagine a future where a diagnosis of Duchenne muscular dystrophy (DMD) doesn’t automatically equate to a rapidly declining quality of life. While currently a devastating genetic disorder, recent advancements, particularly with Satellos Bioscience’s SAT-3247, are hinting at a paradigm shift – ... Read more You can read the full story here: C…Canada · Canada See the Story

Antimalarial drug could treat cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers

In many genetic diseases, a small error in the DNA code can have devastating effects. These errors, called nonsense mutations, insert a premature stop signal in the genetic instructions that cells use to make proteins. As a result, the cell produces only a short, useless fragment of the needed protein. Without the full protein, essential body functions break down. This kind of error appears in a wide range of diseases, including some cancers and…See the Story

Encouraging Results from Phase 1 Trials, Says Satellos Chief Scientific Officer. Now It's On to Phase 2

Satellos Bioscience Chief Scientific Officer discusses early-stage trials of the company's Duchenne muscular dystrophy drug, SAT-3247.Read Article

Kate Masino, MBA, Video Interview | 2025 Emerging Leaders in Healthcare

Kate Masino, MBA, says her career path was changed while watching her chronically ill, aging parents try to navigate the U.S. healthcare system.United States · United States Read Article

A Different Take on the Cause of Duchenne, and a Novel Small-Molecule Treatment to Match

Phil Lambert, Ph.D., chief scientific officer of Satellos Bioscience Inc., explains the mechanism of action of the company's experimental Duchenne muscular dystrophy drug, SAT-3247, and the thinking behind it.Toronto, ON · Toronto Read Article

Ben Scharfe, CPA | 2025 MHE Emerging Leaders in Healthcare

Executive vice president of artificial intelligence, Altera Digital Health. Altera Digital Health provides digital services to healthcare clients.Artificial Intelligence Read Article

Amanda M. Shafton, DNP, CNM, FACNM | 2025 MHE Emerging Leaders in Healthcare

National director of midwifery, Ob Hospitalist Group. Ob Hospitalist Group (OBHG) provides hospitals with obstetric services.United States · United States Read Article

Nancy Hoyt Taff, M.P.H. | 2025 MHE Emerging Leaders in Healthcare

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.Read Article

Breaking News Topics Related to Managed Healthcare Executive